Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The inhibitory effects of okadaic acid on platelet function.

Higashihara M, Takahata K, Kurokawa K, Ikebe M.

FEBS Lett. 1992 Jul 28;307(2):206-10.

4.

Serine/threonine dephosphorylation may be involved in tyrosine phosphorylation: a new mode of signal transduction in platelets.

Artçanuthurry V, Grelac F, Maclouf J, Martin-Cramer E, Levy-Tolédano S.

Semin Thromb Hemost. 1996;22(4):317-26.

PMID:
8944416
5.

Okadaic acid induces marked shape change of human platelets.

Kawakami H, Higashihara M, Song XH, Kurokawa K, Ikebe M, Hirano H.

J Smooth Muscle Res. 1994 Apr;30(2):57-64.

PMID:
8054707
6.

The role of protein phosphatases 1 and 2A in collagen-platelet interaction.

Chiang TM.

Arch Biochem Biophys. 1993 Apr;302(1):56-63.

PMID:
8385905
8.

Calyculin A and okadiac acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A.

Nishikawa M, Toyoda H, Saito M, Morita K, Tawara I, Deguchi K, Kuno T, Shima H, Nagao M, Shirakawa S.

Cell Signal. 1994 Jan;6(1):59-71.

PMID:
8011429
9.

Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.

Asahi M, Yanagi S, Ohta S, Inazu T, Sakai K, Takeuchi F, Taniguchi T, Yamamura H.

FEBS Lett. 1992 Aug 31;309(1):10-4.

10.

The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.

Murata K, Sakon M, Kambayashi J, Yukawa M, Ariyoshi H, Shiba E, Kawasaki T, Kang J, Mori T.

Biochem Int. 1992 Feb;26(2):327-34.

PMID:
1313673
11.
12.

The role of protein kinase C in the initial events of platelet activation by thrombin assessed with a selective inhibitor.

Geanacopoulos M, Turner J, Bowling KE, Vandenberg SR, Gear AR.

Thromb Res. 1993 Jan 1;69(1):113-24.

PMID:
8465270
13.

Inhibitory effect of a toxin okadaic acid, isolated from the black sponge on smooth muscle and platelets.

Karaki H, Mitsui M, Nagase H, Ozaki H, Shibata S, Uemura D.

Br J Pharmacol. 1989 Oct;98(2):590-6.

15.

Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.

Park WH, Kim HK, Nam KS, Shon YH, Jeon BH, Moon SK, Kim MG, Kim CH.

Life Sci. 2004 Nov 5;75(25):3063-76.

PMID:
15474558
16.
18.

Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation.

Ishii H, Kuboki M, Fujii J, Hiraishi S, Kazama M.

Thromb Res. 1990 Mar 15;57(6):847-61.

PMID:
2382255
19.

Specific inhibition of 40 K protein phosphorylation in platelet by a new antithrombotic agent, d-indobufen.

Mamiya S, Hagiwara M, Ishikawa T, Hidaka H.

Thromb Res. 1989 Jun 1;54(5):447-56.

PMID:
2505401
20.

Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.

Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.

Cardiovasc Res. 2006 Jul 15;71(2):393-401. Epub 2006 Mar 22.

PMID:
16713591

Supplemental Content

Support Center